Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing.
about
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Single, very low rituximab dos ...... ing and biosimilarity testing.
@en
Single, very low rituximab dos ...... ing and biosimilarity testing.
@nl
type
label
Single, very low rituximab dos ...... ing and biosimilarity testing.
@en
Single, very low rituximab dos ...... ing and biosimilarity testing.
@nl
prefLabel
Single, very low rituximab dos ...... ing and biosimilarity testing.
@en
Single, very low rituximab dos ...... ing and biosimilarity testing.
@nl
P2093
P2860
P1433
P1476
Single, very low rituximab dos ...... ing and biosimilarity testing.
@en
P2093
Bernd Jilma
Christa Firbas
Christian Schoergenhofer
Johann Bartko
Kalpna Desai
Michael Schwameis
Priya Misra
Raute Sunder Plaßmann
Ulla Derhaschnig
Ulrich Jäger
P2860
P2888
P356
10.1038/S41598-017-17934-6
P407
P577
2018-01-09T00:00:00Z
P6179
1100179045